Pro- and anti-tumour effects of B cells and antibodies in cancer: a comparison of clinical studies and preclinical models Thomas V. GuyAlexandra M. TerryBarbara Fazekas de St Groth Review 24 May 2016 Pages: 885 - 896
Phase I study to evaluate toxicity and feasibility of intratumoral injection of α-gal glycolipids in patients with advanced melanoma Mark R. AlbertiniErik A. RanheimUri Galili Original Article 20 May 2016 Pages: 897 - 907
CTLA-4 in mesothelioma patients: tissue expression, body fluid levels and possible relevance as a prognostic factor Silvio RoncellaStefania LaurentMaria Pia Pistillo Original Article 20 May 2016 Pages: 909 - 917
Regulation of CD40 signaling in colon cancer cells and its implications in clinical tissues Yan ZhouShu-xian ZhouXiao-an Li Original Article 04 June 2016 Pages: 919 - 929
Immunoglobulin G4 (IgG4)-positive plasma cell infiltration is associated with the clinicopathologic traits and prognosis of pancreatic cancer after curative resection Qiaofei LiuZheyu NiuYupei Zhao Original Article 06 June 2016 Pages: 931 - 940
Extension of overall survival beyond objective responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2 David D. StenehjemMichael TooleAjjai Alva Original Article 08 June 2016 Pages: 941 - 949
Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis Markus V. HepptThomas K. EigentlerCarola Berking Original Article 13 June 2016 Pages: 951 - 959
Age-associated impairment of antitumor immunity in carcinoma-bearing mice and restoration by oral administration of Lentinula edodes mycelia extract Satoru IshikawaYasunori MatsuiMamoru Harada Original Article 16 June 2016 Pages: 961 - 972
Optimized magnitude of cryosurgery facilitating anti-tumor immunoreaction in a mouse model of Lewis lung cancer Yusuke TakahashiYotaro IzumiMasafumi Kawamura Original Article 16 June 2016 Pages: 973 - 982
Circulating immune cell phenotype can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma Sung-Eun LeeJi-Young LimChang-Ki Min Original Article 24 June 2016 Pages: 983 - 994
Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy Laurens G. L. SandDagmar BerghuisPancras C. W. Hogendoorn Original Article Open access 01 July 2016 Pages: 995 - 1002
Enhanced binding of necrosis-targeting immunocytokine NHS-IL12 after local tumour irradiation in murine xenograft models Franziska EckertJulia SchmittKarin Schilbach Original Article 04 July 2016 Pages: 1003 - 1013